1. Home > Latest Topics >

Question 12: Fluoroquinolone class effects and relative adverse drug reaction rates

20 June, 2018

Question 12
Could you give an assessment of the safety profile of levofloxacin and comment on where it stands relative to other agents in terms of fluoroquinolone class effects? Also, how would you explain the comparatively low ADR rates associated with levofloxacin?


LATEST TOPICS

Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024
Managing severe infections: Practical approaches for antibiotic use, including combination therapy
05 March, 2024
Updating Traditional Approaches: Expert Insights on Addressing Urinary Tract Infections
26 February, 2024
Antibiotic resistance may be driven by diverse factors, including extreme climatic events
14 February, 2024

RELATED ARTICLES

Lower Respiratory Tract Infection (Pneumonia) – Chapter 3
10 July, 2023
Under the new medical reform, there are challenges for the rational use of antibiotics, making it necessary to adopt coping strategies
20 April, 2023
Observing the Development of Quinolones from the Rational Application of Antibacterial Drugs During the COVID-19 Pandemic
21 March, 2023
Antimicrobial resistance in respiratory tract infections: Current trends and strategies
06 August, 2021
Fluoroquinolones in the management of hospital-acquired pneumonia
20 June, 2023